Japan's Daiichi Sankyo Co said on Tuesday its mRNA-based COVID-19 vaccine had reached its primary endpoint in a trial of the shot as a booster.
A man walks past a sign of Japanese pharmaceutical company Daiichi Sankyo Co., Ltd. at the company's head office in Tokyo July 17, 2009. REUTERS/Stringersaid on Tuesday its mRNA-based COVID-19 vaccine had reached its primary endpoint in a trial of the shot as a booster.
In a trial of about 5,000 Japanese adults, those who had received the vaccine, known as DS-5670, developed levels of COVID-neutralising antibodies that were as good as or better than those of people who had had other mRNA shots, the company said in a release.Approval would give Japan a home-grown source for mRNA vaccines, which have made up the bulk of its COVID inoculations to date.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
As Pandemic Aid Dries Up, Businesses Chase Covid Tax CreditThe employee-retention tax credit ended last year, but it’s still bringing billions to businesses, fueling a pop-up industry and prompting IRS scrutiny
Read more »
My Kids Are Revolting Against Mean Aunt Ruth. Do They Have to Talk to Her at Thanksgiving?Dear Care and Feeding: I feel for my sister, but I also understand why my kids want to keep their distance.
Read more »
Cruise ship with 800 COVID-positive passengers docks in AustraliaThe Majestic Princess cruise ship began seeing an increase in positive cases halfway through its 12-day journey, Carnival Australia president Marguerite Fitzgerald told reporters in a media briefing on Saturday.
Read more »
Asian benchmarks mixed as markets eye COVID, inflation risksAsian shares are mixed as momentum fades from last week’s rally on Wall Street amid varied sentiments about coronavirus restrictions easing in China and global interest rate increases.
Read more »
The International Community Must Prioritize COVID Treatment and Test AccessGlobal trade rules are extending the COVID pandemic
Read more »